Aimedis
AIMX
Share
Rank #12
On 0 watchlist
Type META

$0.015

Market Cap 4,721,001
24 Hour Trading Vol -
Fully Diluted Valuation -
Circulating Supply 260,000,000
Total Supply 588,000,000
Max Supply 600,000,000
1D 1W 1M
0.00 0.00 -
AIMX
USD

About Aimedis

Aimedis - an eHealth platform based on blockchain technology, which has been developed since 2017 and released in the current version 2020 for web, iOS and Android. Aimedis combines eHealth applications such as health records, video chat with doctors, appointments, prescriptions, second opinions, wearables, emergency records and much more along with medical social media platform, eLearning, eTeaching and education, a unique medical and scientific-pharmaceutical NFT marketplace, while displaying all relevant operations in a private blockchain, visible and transparent for patients and healthcare professionals. Aimedis builds the world’s first medical metaverse and opens the world’s first virtual hospital chain in the metaverse while offering space to other hospitals, companies, universities and people. The Aimedis token, which is tailored to the platform, is much more than just utility and payment tokens, it also offers staking, governance, DeFi (the first medical DeFi token) and the next hot trend in the field of cryptocurrencies, social token functionalities. The Aimedis NFTs are a revolutionary tool for medical data along with functionalities inside the Aimedis metaverse.

Vote for AIMX Today

Important Disclaimer None of the content on this website is considered as financial advice or any other advice. Do your own research before investing. Any content herein should be analysed and verified before relying on them. All content provided herein our website is general information for entertainment purposes. All information, hyperlinked sites, blogs, discussions, comments, ratings, social media accounts mentioned here, are attained from third party sources. We make no guarantees or warranties of any kind in relation to our websites content, including but not limited to accuracy and updatedness. Any use or reliance on the content provided on this site is solely at your own risk and discretion. Trading is a highly risky activity that can lead to major losses, please consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.